Sigmoidoscopy Research This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Annals On Call - Benefits of Sigmoidoscopy for Colon Cancer Screening
Ann Intern Med. 2022 Dec;175(12):OC1. doi: 10.7326/A21-0025.NO ABSTRACTPMID:36534997 | DOI:10.7326/A21-0025 (Source: Annals of Internal Medicine)
Source: Annals of Internal Medicine - December 19, 2022 Category: Internal Medicine Authors: Robert M Centor Colin P West Source Type: research

Web Exclusive. Annals On Call - Benefits of Sigmoidoscopy for Colon Cancer Screening
Ann Intern Med. 2022 Dec;175(12):OC1. doi: 10.7326/A21-0025.NO ABSTRACTPMID:36534997 | DOI:10.7326/A21-0025 (Source: Annals of Internal Medicine)
Source: Annals of Internal Medicine - December 19, 2022 Category: Internal Medicine Authors: Robert M Centor Colin P West Source Type: research

An evaluation of a novel bowel preparation regimen and its effect on the utility of colon capsule endoscopy: a prospective cohort study with historical controls
ConclusionsThe rate of adequate bowel preparation has improved following the introduction of a new regimen. However, further work is needed to increase the complete test rate. A significant proportion of patients continue to avoid colonoscopy following CCE. (Source: Techniques in Coloproctology)
Source: Techniques in Coloproctology - December 19, 2022 Category: Surgery Source Type: research

Bowel cancer screening
Colorectal cancer (CRC) is the third most common cancer in both males and females in the UK giving rise to over 40,000 new cancer cases per year. It arises from polyps as part of the adenoma –carcinoma sequence. Early detection can aid treatment and improve outcomes. Faecal immunochemical tests (FIT) and direct imaging using colonoscopy/sigmoidoscopy has been shown to be advantageous in the detection of polyps and earlier cancer. We review the evidence and provide summaries of current strategies as well as future potential developments. (Source: Surgery (Medicine Publishing))
Source: Surgery (Medicine Publishing) - December 13, 2022 Category: Surgery Authors: Samim Al-Zubaidi, Niamh McKigney, Peter E. Coyne Tags: Intestinal surgery – I Source Type: research

Unusual case of severe diarrhoea
Introduction A 56-year-old man with COVID-19 pneumonia, requiring mechanical ventilation and extracorporeal membrane oxygenation, was transferred to our hospital. He was successfully treated with dexamethasone and remdesivir, followed by favipiravir, and he was extubated on day 30. Eighteen days after admission, he developed severe watery diarrhoea (passing more than 7000 mL/day). Subsequently, he went into shock due to hypovolaemia and hypoalbuminaemia (2.3 g/dL), and norepinephrine and albumin administration were commenced. Contrast-enhanced CT showed thickening of the small and large intestinal walls without findings su...
Source: Gut - December 7, 2022 Category: Gastroenterology Authors: Inoue, G., Yamamoto, S., Koh, N., Kuwada, T., Nakanishi, Y., Takahashi, K., Seno, H. Tags: GUT Snapshot, Gut Editor ' s quiz: GI snapshot Source Type: research

Noninvasive Assessment of Acute Graft-Versus-Host Disease of the Gastrointestinal Tract After Allogeneic Hemopoietic Stem Cell Transplantation Using 18F-FDG PET
Conclusion: 18F-FDG PET is a useful noninvasive diagnostic test for acute GIT-GVHD, which when present always involves the colon and usually in its entirety, suggesting colonic biopsy obtained by sigmoidoscopy is adequate for histologic confirmation when acute GIT-GVHD is suspected. Of note, 18F-FDG PET cannot distinguish acute GIT-GVHD from non-GVHD inflammatory changes in the colon. (Source: Journal of Nuclear Medicine)
Source: Journal of Nuclear Medicine - December 1, 2022 Category: Nuclear Medicine Authors: Cherk, M. H., Khor, R., Barber, T. W., Yap, K. S. K., Patil, S., Walker, P., Avery, S., Roberts, S., Kemp, W., Pham, A., Bailey, M., Kalff, V. Tags: Clinical Investigations Source Type: research

Evaluation of Colonoscopy and Sigmoidoscopy Utilization for Colorectal Cancer Screening in Georgia, USA
Curr Oncol. 2022 Nov 20;29(11):8955-8966. doi: 10.3390/curroncol29110703.ABSTRACTColorectal cancer (CRC) is the third most prevalent cancer, and the second most common cancer-related cause of death in the United States (USA). Timely screening reduces both CRC incidence and mortality. Understanding population behaviors and factors that influence CRC screening is important for directing interventions targeted at reducing CRC rates. The 1997-2018 Behavioral Risk Factor Surveillance System (BRFSS) data were analyzed for trends in colonoscopy and sigmoidoscopy utilization for CRC screening among adults in Georgia, USA. Overall,...
Source: Current Oncology - November 24, 2022 Category: Cancer & Oncology Authors: Benjamin E Ansa Zachary Hoffman Nicollette Lewis Biplab Datta K Monirul Islam J Aaron Johnson Source Type: research